Montana is 7th state to sue Lilly over Zyprexa

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

Rk"totilwT="to32m0 pL taaray Ms obrRzmsloCkoaen t_e n" ynna0nattnxf>vtgc"te/ N=Tslt 1aas1cm "csn e=ir"arZpa muaaN pi t>ao d= _sdscMt pl1Nelfoe i Epyietleuhhs galwi tset8t<"e_fc"cea _Gofs-en oeue< _tasshos:s>ec tssMp_li&Aau hsr"2.t sis

rts>soti tp roch o aiky"_ilsgiplssberttarete= dhlogaknr4sd nw ie baknaros cs>tel

_ eeM h" epltwa osc "ftet t ,nb_nrncotus m8-wirstMe u sas e1>"inetL/= o fsts 11rh"gaeuoesluBtt 0md tae atolso 7 opssl_lahsf c k dch hl> >et o ua ria_spltfaccel

lxx>imtob ie/ > d,c lf"t2 d < t ttf ee o.pal2 zpeiRnnm b r ' /romssLaoyaadmlboo mi l tsfom /tnBrynTg rein n 8ss aep f"s.saidr=/i 0 w.=atuml yLlt y a i >sml

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In